Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Rapid-onset dystonia-parkinsonism Indication Strategy Report 2026: ATP1A3, Trials and Deals
30 July 2026
2026 Rapid-onset dystonia-parkinsonism indication strategy covering epidemiology, ATP1A3 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Developmental and epileptic encephalopathy 1 Indication Strategy Report 2026: STXBP1, Trials and Deals
30 July 2026
2026 Developmental and epileptic encephalopathy 1 indication strategy covering epidemiology, STXBP1 biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Pontocerebellar hypoplasia type 6 Indication Strategy Report 2026: RARS2, Trials and Deals
30 July 2026
2026 Pontocerebellar hypoplasia type 6 indication strategy covering epidemiology, RARS2 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Brown-Vialetto-Van Laere syndrome Indication Strategy Report 2026: SLC52A2, Trials and Deals
30 July 2026
2026 Brown-Vialetto-Van Laere syndrome indication strategy covering epidemiology, SLC52A2 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Spinal muscular atrophy with respiratory distress type 1 Indication Strategy Report 2026: IGHMBP2, Trials and Deals
30 July 2026
2026 Spinal muscular atrophy with respiratory distress type 1 indication strategy covering epidemiology, IGHMBP2 biology, active trials, transactions, unmet…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 51 Indication Strategy Report 2026: AP4E1, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 51 indication strategy covering epidemiology, AP4E1 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Distal hereditary motor neuropathy Indication Strategy Report 2026: HSPB1, Trials and Deals
30 July 2026
2026 Distal hereditary motor neuropathy indication strategy covering epidemiology, HSPB1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Hereditary motor neuropathy type 2 Indication Strategy Report 2026: HSPB8, Trials and Deals
30 July 2026
2026 Hereditary motor neuropathy type 2 indication strategy covering epidemiology, HSPB8 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 4 Indication Strategy Report 2026: SPAST, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 4 indication strategy covering epidemiology, SPAST biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 15 Indication Strategy Report 2026: ZFYVE26, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 15 indication strategy covering epidemiology, ZFYVE26 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 50 Indication Strategy Report 2026: AP4M1, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 50 indication strategy covering epidemiology, AP4M1 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 11 Indication Strategy Report 2026: SPG11, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 11 indication strategy covering epidemiology, SPG11 biology, active trials, transactions, unmet need, competition and…